BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech Grant Program
- Written by PR Newswire
![]() |
- Recognition of outstanding in-vivo outcomes from a lead RNA program in CNS
- Underpinned by proprietary IV-formulated, Brain-targeting Ribonucleic Acid Interference (RNAi) Nanomedicine (BTRiNTM) platform
- BIORCHESTRA to receive in-kind products and services from Merck Group
CAMBRIDGE, Mass. and DAEJEON, South Korea, July 17, 2023 /PRNewswire/...
Read more: BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech Grant Program















